FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:ABR-DDX42

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: ABR-DDX42
FusionPDB ID: 548
FusionGDB2.0 ID: 548
HgeneTgene
Gene symbol

ABR

DDX42

Gene ID

29

11325

Gene nameABR activator of RhoGEF and GTPaseDEAD-box helicase 42
SynonymsMDBDDX42P|RHELP|RNAHP|SF3B8|SF3b125
Cytomap

17p13.3

17q23.3

Type of geneprotein-codingprotein-coding
Descriptionactive breakpoint cluster region-related proteinABR, RhoGEF and GTPase activating proteinactive BCR-relatedATP-dependent RNA helicase DDX42DEAD (Asp-Glu-Ala-Asp) box helicase 42DEAD (Asp-Glu-Ala-Asp) box polypeptide 42SF3b DEAD box proteinsplicing factor 3B-associated 125 kDa proteinsplicing factor 3b, subunit 8
Modification date2020031320200313
UniProtAcc

Q15018

Main function of 5'-partner protein: FUNCTION: Component of the BRISC complex, a multiprotein complex that specifically cleaves 'Lys-63'-linked polyubiquitin, leaving the last ubiquitin chain attached to its substrates (PubMed:19214193, PubMed:20032457, PubMed:20656690, PubMed:24075985). May act as a central scaffold protein that assembles the various components of the BRISC complex and retains them in the cytoplasm (PubMed:20656690). Plays a role in regulating the onset of apoptosis via its role in modulating 'Lys-63'-linked ubiquitination of target proteins (By similarity). Required for normal mitotic spindle assembly and microtubule attachment to kinetochores via its role in deubiquitinating NUMA1 (PubMed:26195665). Plays a role in interferon signaling via its role in the deubiquitination of the interferon receptor IFNAR1; deubiquitination increases IFNAR1 activities by enhancing its stability and cell surface expression (PubMed:24075985, PubMed:26344097). Down-regulates the response to bacterial lipopolysaccharide (LPS) via its role in IFNAR1 deubiquitination (PubMed:24075985). Required for normal induction of p53/TP53 in response to DNA damage (PubMed:25283148). Independent of the BRISC complex, promotes interaction between USP7 and p53/TP53, and thereby promotes deubiquitination of p53/TP53, preventing its degradation and resulting in increased p53/TP53-mediated transcription regulation and p53/TP53-dependent apoptosis in response to DNA damage (PubMed:25283148). {ECO:0000250|UniProtKB:Q3TCJ1, ECO:0000269|PubMed:19214193, ECO:0000269|PubMed:20032457, ECO:0000269|PubMed:20656690, ECO:0000269|PubMed:24075985, ECO:0000269|PubMed:25283148}.

Q86XP3

Main function of 5'-partner protein: FUNCTION: ATP-dependent RNA helicase. Binds to partially double-stranded RNAs (dsRNAs) in order to unwind RNA secondary structures. Unwinding is promoted in the presence of single-strand binding proteins. Mediates also RNA duplex formation thereby displacing the single-strand RNA binding protein. ATP and ADP modulate its activity: ATP binding and hydrolysis by DDX42 triggers RNA strand separation, whereas the ADP-bound form of the protein triggers annealing of complementary RNA strands. Involved in the survival of cells by interacting with TP53BP2 and thereby counteracting the apoptosis-stimulating activity of TP53BP2. Relocalizes TP53BP2 to the cytoplasm. {ECO:0000269|PubMed:16397294, ECO:0000269|PubMed:19377511}.
Ensembl transtripts involved in fusion geneENST idsENST00000291107, ENST00000302538, 
ENST00000536794, ENST00000544583, 
ENST00000574437, ENST00000543210, 
ENST00000572441, ENST00000573895, 
ENST00000582985, ENST00000359353, 
ENST00000389924, ENST00000457800, 
ENST00000578681, ENST00000583590, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score23 X 15 X 14=483015 X 18 X 10=2700
# samples 3618
** MAII scorelog2(36/4830*10)=-3.74595437739346
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(18/2700*10)=-3.90689059560852
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: ABR [Title/Abstract] AND DDX42 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: ABR [Title/Abstract] AND DDX42 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)ABR(953290)-DDX42(61882431), # samples:1
Anticipated loss of major functional domain due to fusion event.ABR-DDX42 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
ABR-DDX42 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
ABR-DDX42 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
ABR-DDX42 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
ABR-DDX42 seems lost the major protein functional domain in Hgene partner, which is a kinase due to the frame-shifted ORF.
ABR-DDX42 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneABR

GO:0090630

activation of GTPase activity

7479768

TgeneDDX42

GO:0008104

protein localization

19377511



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr17:953290/chr17:61882431)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across ABR (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across DDX42 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000302538ABRchr17953290-ENST00000578681DDX42chr1761882431+5053193814741331328
ENST00000302538ABRchr17953290-ENST00000583590DDX42chr1761882431+5053193814741331328
ENST00000302538ABRchr17953290-ENST00000359353DDX42chr1761882431+4134193814741331328
ENST00000302538ABRchr17953290-ENST00000389924DDX42chr1761882431+5052193814741331328
ENST00000302538ABRchr17953290-ENST00000457800DDX42chr1761882431+5052193814741331328
ENST00000574437ABRchr17953290-ENST00000578681DDX42chr1761882431+5233211812343131396
ENST00000574437ABRchr17953290-ENST00000583590DDX42chr1761882431+5233211812343131396
ENST00000574437ABRchr17953290-ENST00000359353DDX42chr1761882431+4314211812343131396
ENST00000574437ABRchr17953290-ENST00000389924DDX42chr1761882431+5232211812343131396
ENST00000574437ABRchr17953290-ENST00000457800DDX42chr1761882431+5232211812343131396
ENST00000291107ABRchr17953290-ENST00000578681DDX42chr1761882431+482717123239071291
ENST00000291107ABRchr17953290-ENST00000583590DDX42chr1761882431+482717123239071291
ENST00000291107ABRchr17953290-ENST00000359353DDX42chr1761882431+390817123239071292
ENST00000291107ABRchr17953290-ENST00000389924DDX42chr1761882431+482617123239071291
ENST00000291107ABRchr17953290-ENST00000457800DDX42chr1761882431+482617123239071291
ENST00000536794ABRchr17953290-ENST00000578681DDX42chr1761882431+4539142414036191159
ENST00000536794ABRchr17953290-ENST00000583590DDX42chr1761882431+4539142414036191159
ENST00000536794ABRchr17953290-ENST00000359353DDX42chr1761882431+3620142414036191160
ENST00000536794ABRchr17953290-ENST00000389924DDX42chr1761882431+4538142414036191159
ENST00000536794ABRchr17953290-ENST00000457800DDX42chr1761882431+4538142414036191159

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000302538ENST00000578681ABRchr17953290-DDX42chr1761882431+0.0002405480.9997595
ENST00000302538ENST00000583590ABRchr17953290-DDX42chr1761882431+0.0002405480.9997595
ENST00000302538ENST00000359353ABRchr17953290-DDX42chr1761882431+0.0005010040.99949896
ENST00000302538ENST00000389924ABRchr17953290-DDX42chr1761882431+0.0002396390.9997603
ENST00000302538ENST00000457800ABRchr17953290-DDX42chr1761882431+0.0002396390.9997603
ENST00000574437ENST00000578681ABRchr17953290-DDX42chr1761882431+0.0002937360.9997062
ENST00000574437ENST00000583590ABRchr17953290-DDX42chr1761882431+0.0002937360.9997062
ENST00000574437ENST00000359353ABRchr17953290-DDX42chr1761882431+0.0006161770.9993838
ENST00000574437ENST00000389924ABRchr17953290-DDX42chr1761882431+0.0002925120.9997075
ENST00000574437ENST00000457800ABRchr17953290-DDX42chr1761882431+0.0002925120.9997075
ENST00000291107ENST00000578681ABRchr17953290-DDX42chr1761882431+0.0001936660.99980634
ENST00000291107ENST00000583590ABRchr17953290-DDX42chr1761882431+0.0001936660.99980634
ENST00000291107ENST00000359353ABRchr17953290-DDX42chr1761882431+0.0003977180.99960226
ENST00000291107ENST00000389924ABRchr17953290-DDX42chr1761882431+0.0001929950.99980706
ENST00000291107ENST00000457800ABRchr17953290-DDX42chr1761882431+0.0001929950.99980706
ENST00000536794ENST00000578681ABRchr17953290-DDX42chr1761882431+0.0002970890.9997029
ENST00000536794ENST00000583590ABRchr17953290-DDX42chr1761882431+0.0002970890.9997029
ENST00000536794ENST00000359353ABRchr17953290-DDX42chr1761882431+0.0006938810.9993061
ENST00000536794ENST00000389924ABRchr17953290-DDX42chr1761882431+0.0002955390.9997044
ENST00000536794ENST00000457800ABRchr17953290-DDX42chr1761882431+0.0002955390.9997044

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for ABR-DDX42

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
ABRchr17953290DDX42chr17618824311424427NEIVDKIMGKGQIQIDYPPFEKNFYN
ABRchr17953290DDX42chr17618824311712559NEIVDKIMGKGQIQIDYPPFEKNFYN
ABRchr17953290DDX42chr17618824311938596NEIVDKIMGKGQIQIDYPPFEKNFYN
ABRchr17953290DDX42chr17618824312118664NEIVDKIMGKGQIQIDYPPFEKNFYN

Top

Potential FusionNeoAntigen Information of ABR-DDX42 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
ABR-DDX42_953290_61882431.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
ABR-DDX42chr17953290chr17618824311712HLA-B15:03IQIDYPPF0.98040.72261220
ABR-DDX42chr17953290chr17618824311712HLA-B52:01IQIDYPPF0.78550.94321220
ABR-DDX42chr17953290chr17618824311712HLA-A02:13IMGKGQIQI0.97560.6028615
ABR-DDX42chr17953290chr17618824311712HLA-A02:38IMGKGQIQI0.91520.6751615
ABR-DDX42chr17953290chr17618824311712HLA-A02:19IMGKGQIQI0.91320.5491615
ABR-DDX42chr17953290chr17618824311712HLA-B13:02IMGKGQIQI0.15620.7849615

Top

Potential FusionNeoAntigen Information of ABR-DDX42 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
ABR-DDX42_953290_61882431.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
ABR-DDX42chr17953290chr17618824311712DRB1-0301KGQIQIDYPPFEKNF924
ABR-DDX42chr17953290chr17618824311712DRB1-0301GKGQIQIDYPPFEKN823
ABR-DDX42chr17953290chr17618824311712DRB1-0310GKGQIQIDYPPFEKN823
ABR-DDX42chr17953290chr17618824311712DRB1-0310KGQIQIDYPPFEKNF924
ABR-DDX42chr17953290chr17618824311712DRB1-0310MGKGQIQIDYPPFEK722
ABR-DDX42chr17953290chr17618824311712DRB1-0313KGQIQIDYPPFEKNF924
ABR-DDX42chr17953290chr17618824311712DRB1-0313GKGQIQIDYPPFEKN823
ABR-DDX42chr17953290chr17618824311712DRB1-0315GKGQIQIDYPPFEKN823
ABR-DDX42chr17953290chr17618824311712DRB1-0315KGQIQIDYPPFEKNF924
ABR-DDX42chr17953290chr17618824311712DRB1-0318KGQIQIDYPPFEKNF924
ABR-DDX42chr17953290chr17618824311712DRB1-0318GKGQIQIDYPPFEKN823
ABR-DDX42chr17953290chr17618824311712DRB1-0322KGQIQIDYPPFEKNF924
ABR-DDX42chr17953290chr17618824311712DRB1-0322GKGQIQIDYPPFEKN823
ABR-DDX42chr17953290chr17618824311712DRB1-0326KGQIQIDYPPFEKNF924
ABR-DDX42chr17953290chr17618824311712DRB1-0326GKGQIQIDYPPFEKN823
ABR-DDX42chr17953290chr17618824311712DRB1-0328KGQIQIDYPPFEKNF924
ABR-DDX42chr17953290chr17618824311712DRB1-0328GKGQIQIDYPPFEKN823
ABR-DDX42chr17953290chr17618824311712DRB1-0330KGQIQIDYPPFEKNF924
ABR-DDX42chr17953290chr17618824311712DRB1-0330GKGQIQIDYPPFEKN823
ABR-DDX42chr17953290chr17618824311712DRB1-0332KGQIQIDYPPFEKNF924
ABR-DDX42chr17953290chr17618824311712DRB1-0332GKGQIQIDYPPFEKN823
ABR-DDX42chr17953290chr17618824311712DRB1-0334KGQIQIDYPPFEKNF924
ABR-DDX42chr17953290chr17618824311712DRB1-0334GKGQIQIDYPPFEKN823
ABR-DDX42chr17953290chr17618824311712DRB1-0336KGQIQIDYPPFEKNF924
ABR-DDX42chr17953290chr17618824311712DRB1-0336GKGQIQIDYPPFEKN823
ABR-DDX42chr17953290chr17618824311712DRB1-0342KGQIQIDYPPFEKNF924
ABR-DDX42chr17953290chr17618824311712DRB1-0342GKGQIQIDYPPFEKN823
ABR-DDX42chr17953290chr17618824311712DRB1-0342MGKGQIQIDYPPFEK722
ABR-DDX42chr17953290chr17618824311712DRB1-0344KGQIQIDYPPFEKNF924
ABR-DDX42chr17953290chr17618824311712DRB1-0344GKGQIQIDYPPFEKN823
ABR-DDX42chr17953290chr17618824311712DRB1-0346KGQIQIDYPPFEKNF924
ABR-DDX42chr17953290chr17618824311712DRB1-0346GKGQIQIDYPPFEKN823
ABR-DDX42chr17953290chr17618824311712DRB1-0348KGQIQIDYPPFEKNF924
ABR-DDX42chr17953290chr17618824311712DRB1-0348GKGQIQIDYPPFEKN823
ABR-DDX42chr17953290chr17618824311712DRB1-0350KGQIQIDYPPFEKNF924
ABR-DDX42chr17953290chr17618824311712DRB1-0350GKGQIQIDYPPFEKN823
ABR-DDX42chr17953290chr17618824311712DRB1-0352KGQIQIDYPPFEKNF924
ABR-DDX42chr17953290chr17618824311712DRB1-0352GKGQIQIDYPPFEKN823
ABR-DDX42chr17953290chr17618824311712DRB1-0354KGQIQIDYPPFEKNF924
ABR-DDX42chr17953290chr17618824311712DRB1-0354GKGQIQIDYPPFEKN823
ABR-DDX42chr17953290chr17618824311712DRB1-0422KGQIQIDYPPFEKNF924
ABR-DDX42chr17953290chr17618824311712DRB1-0422GKGQIQIDYPPFEKN823
ABR-DDX42chr17953290chr17618824311712DRB1-0462GKGQIQIDYPPFEKN823
ABR-DDX42chr17953290chr17618824311712DRB1-0467GKGQIQIDYPPFEKN823
ABR-DDX42chr17953290chr17618824311712DRB1-0467KGQIQIDYPPFEKNF924
ABR-DDX42chr17953290chr17618824311712DRB1-1394GKGQIQIDYPPFEKN823
ABR-DDX42chr17953290chr17618824311712DRB1-1394KGQIQIDYPPFEKNF924
ABR-DDX42chr17953290chr17618824311712DRB1-1455VDKIMGKGQIQIDYP318
ABR-DDX42chr17953290chr17618824311712DRB1-1476GKGQIQIDYPPFEKN823
ABR-DDX42chr17953290chr17618824311712DRB1-1476KGQIQIDYPPFEKNF924
ABR-DDX42chr17953290chr17618824311712DRB1-1476MGKGQIQIDYPPFEK722
ABR-DDX42chr17953290chr17618824311712DRB1-1479GKGQIQIDYPPFEKN823
ABR-DDX42chr17953290chr17618824311712DRB1-1479KGQIQIDYPPFEKNF924
ABR-DDX42chr17953290chr17618824311712DRB1-1479MGKGQIQIDYPPFEK722
ABR-DDX42chr17953290chr17618824311712DRB3-0204KGQIQIDYPPFEKNF924
ABR-DDX42chr17953290chr17618824311712DRB3-0204GKGQIQIDYPPFEKN823

Top

Fusion breakpoint peptide structures of ABR-DDX42

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
3833IMGKGQIQIDYPPFABRDDX42chr17953290chr17618824311712

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of ABR-DDX42

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN3833IMGKGQIQIDYPPF-5.09731-5.09731
HLA-A11:014UQ23833IMGKGQIQIDYPPF-6.94957-6.94957
HLA-A24:025HGA3833IMGKGQIQIDYPPF-7.40535-7.40535

Top

Vaccine Design for the FusionNeoAntigens of ABR-DDX42

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
ABR-DDX42chr17953290chr17618824311220IQIDYPPFCAGATTGACTATCCACCATTTGAA
ABR-DDX42chr17953290chr1761882431615IMGKGQIQIATGGGCAAAGGACAGATCCAGATTGAC

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
ABR-DDX42chr17953290chr1761882431318VDKIMGKGQIQIDYPGACAAGATCATGGGCAAAGGACAGATCCAGATTGACTATCCACCA
ABR-DDX42chr17953290chr1761882431722MGKGQIQIDYPPFEKGGCAAAGGACAGATCCAGATTGACTATCCACCATTTGAAAAAAAC
ABR-DDX42chr17953290chr1761882431823GKGQIQIDYPPFEKNAAAGGACAGATCCAGATTGACTATCCACCATTTGAAAAAAACTTT
ABR-DDX42chr17953290chr1761882431924KGQIQIDYPPFEKNFGGACAGATCCAGATTGACTATCCACCATTTGAAAAAAACTTTTAC

Top

Information of the samples that have these potential fusion neoantigens of ABR-DDX42

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
UVMABR-DDX42chr17953290ENST00000291107chr1761882431ENST00000359353TCGA-V4-A9EI

Top

Potential target of CAR-T therapy development for ABR-DDX42

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to ABR-DDX42

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to ABR-DDX42

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource